Characteristics and external validity of the German Health Risk Institute (HRI) Database

Pharmacoepidemiology and Drug Safety

Volumn 25, Issue 1, 2016, Pages 106-109

  Andersohn, Frank ^a,b   Walker, Jochen ^c,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Frank Andersohn Consulting and Research Services   (Germany)

^c ELSEVIER MASSON   (France)

^d Health Risk Institute   (Germany)

Author keywords

Data sources; External validity; Germany; Healthcare databases; Pharmacoepidemiology; Secondary data

Indexed keywords

ADULT; ARTICLE; DATA BASE; DRUG USE; EPIDEMIOLOGICAL DATA; EXTERNAL VALIDITY; FEMALE; GERMANY; HEALTH HAZARD; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; MALE; MORBIDITY; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; FACTUAL DATABASE; HEALTH STATUS INDICATOR; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH; RURAL POPULATION; STATISTICS AND NUMERICAL DATA; URBAN POPULATION;

ADULT; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; FEMALE; GERMANY; HEALTH STATUS INDICATORS; HOSPITALIZATION; HUMANS; INSURANCE, HEALTH; MALE; NATIONAL HEALTH PROGRAMS; RURAL POPULATION; URBAN POPULATION;

EID: 84953838703     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3895     Document Type: Article

References (10)

1. The Pharmaceutical Industry in Figures - Key Data 2015. European Federation of Pharmaceutical Industries and Associations; 2015. http://www.efpia.eu/uploads/Figures_2015_Key_data.pdf (accessed 2 July 2015).
2. Hoffmann F. Review on use of German health insurance medication claims data for epidemiological research. Pharmacoepidemiol Drug Saf 2009; 18(5): 349-356.
3. Pigeot I, Ahrens W. Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations. Pharmacoepidemiol Drug Saf 2008; 17(3): 215-223.
4. Ihle P, Köster I, Herholz H, et al. Sample survey of persons insured in statutory health insurance institutions in Hessen-concept and realisation of person-related data base] [Article in German. Gesundheitswesen 2005; 67(8-9): 638-645.
5. The Information System of the Federal Health Monitoring 2013. https://www.gbe-bund.de (accessed June 02, 2015).
6. Schwabe U, Paffrath D (ed.). Arzneiverordnungs-Report 2014. Springer: Heidelberg 2014.
7. Andersohn F, Schlattmann P, Roll S, et al. Regional variation of mortality from ischemic heart disease in Germany from 1998 to 2007. Clin Res Cardiol 2010; 99(8): 511-518.
8. Müller-Nordhorn J, Rossnagel K, Mey W, et al. Regional variation and time trends in mortality from ischaemic heart disease: East and West Germany 10years after reunification. J Epidemiol Community Health 2004; 58(6): 481-485.
9. Ohlmeier C, Langner I, Hillebrand K, et al. Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study. BMC Public Health 2015; 15: 570.
10. Hoffmann F, Icks A. Structural differences between health insurance funds and their impact on health services research: results from the Bertelsmann Health-Care Monitor]. [Article in German. Gesundheitswesen 2012; 74(5): 291-297.